NCT02324764View on ClinicalTrials.gov

Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography

NACompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2019

Study Completion Date

March 21, 2019

Conditions

Embolism and Thrombosis of the Radial ArteryCoronary Heart Disease

Interventions

DEVICE

Glidesheath Slender

testing the efficacy and safety of the new transradial sheath in comparison to the standard 6 french sheath.

DEVICE

standard 6- French radial sheath

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT02324764 - Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography | Biotech Hunter | Biotech Hunter